mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
Curcumin |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
SB 216763 |
GDSC1000 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
betulinic acid |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
JW-480 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |